Finally, Dr. Pierorazio shares two of his personal tips for wellness. He avidly journals each day in order to exercise gratitude, reflect on his day, and set priorities for the next day. Finally, he emphasizes the importance of finding a wellness mentor or counselor in order to expand surgeon wellness and talent.
Read MoreJonathan Hester is a campaign official with the Governor of Alabama and a testicular cancer survivor. Jonathan talks about discovering his testicular cancer, not letting his diagnosis get in the way of living his life, Governor Kay Ivey proclaiming April 2022 as Testicular Cancer Awareness Month, his extensive work as an awareness advocate in his community, and much more!
Read MoreWe are excited to welcome John Klish (Klishy) as a guest speaker at the Testicular Cancer Conference 2018. John Klish was born with bi-lateral profound hearing loss, meaning profoundly deaf. That didn’t stop him from following his dreams. He graduated from Colorado State University with a degree in mechanical engineering while racing on the collegiate cycling team.
Read MoreWe are excited to welcome Tom Willner as a guest speaker at the Testicular Cancer Conference 2018. Tom Willner, President of Tom Willner Music and co-founder of Center Stage Education, is a musician, published songwriter, playwright, speaker, and author. He is a testicular cancer survivor who has written a musical and a book about his experience that raise awareness and funding for cancer charities, and teach healthcare professionals about the patient experience.
Read MoreWe are excited to welcome back Dr. Lawrence Einhorn as our honorary guest speaker, world renowned tc medical expert at our Testicular Cancer Conference 2018. Lawrence Einhorn, MD, has been on the IU School of Medicine Department of Medicine faculty since 1973. His field of expertise includes clinical trials and supportive care, with focus in the areas of lung and testicular cancers. Dr. Einhorn has also been involved in the clinical development of new drug therapies. Studies chaired by Dr. Einhorn at IU School of Medicine in testicular cancer led to the FDA approval of cisplatin, etoposide and ifosfamide. In addition, his groups conducted the pivotal studies that led to the approval of both gemcitabine and pemetrexed in non-small cell lung cancer. Dr. Einhorn’s studies helped to save many lives turning testicular cancer into a highly curable cancer with a 90% overall survival rate.
Read MoreWe are excited and honored to welcome back Dr. Ajay K. Nangia as a guest speaker at the Testicular Cancer Conference 2018. Dr. Ajay K. Nangia is Professor and Vice-Chair of Urology at the University of Kansas Medical Center. Dr. Nangia received his medical degree from St. Thomas and Guy's Hospital Medical School in London, U.K. He completed two years of research at Yale University prior to residency. He completed his Urology residency at the University of Pittsburgh Medical Center and a Male Infertility and Microsurgery fellowship at the Cleveland Clinic Foundation in Cleveland, Ohio. Dr. Nangia was at Dartmouth-Hitchcock Medical Center in New Hampshire prior to coming to Kansas. Dr. Nangia is a fellowship trained male infertility specialist in the metropolitan Kansas City area with 18 years of experience and national involvement in the field. He is one of the leading male infertility specialists nationally. He has extensive experience in male infertility, urological microsurgical reconstruction, including vasectomy reversals in the Kansas, Western Missouri, Oklahoma and Nebraska region. He also specializes in Men's Health issues as they relate to sexual and reproductive health, especially male contraception, testosterone deficiency, erectile dysfunction and ejaculatory problems. He and Dr. Broghammer have one of the largest practices in surgical correction for erectile dysfunction (penile prostheses) in the region. He also specializes in fertility and sexual dysfunction issues related to spinal cord injuries and pre- and post-cancer treatment. Dr. Nangia is a leading national specialist in the field of male infertility, vasectomy reversals, vasectomies and complications from vasectomies. He also has a secondary specialty in stone disease.
Read MoreWe are excited and honored to welcome back Dr. Nicholas Cost as a guest speaker at the Testicular Cancer Conference 2018. Dr. Nicholas Cost is a assistant professor, surgery-urology at University of Colorado Anschutz Medical Campus. Dr. Cost’s interest in testicular cancer has guided his training and career development. Testicular cancer is a disease that affects boys and men of all ages. For that reason, after completing his residency in Urology and Urologic Surgery, he pursued fellowship training in both urologic oncology (cancer treatment) and pediatric urology. This allows him to provide care to children, adolescents, and adults with testicular cancer at both “adult” and “pediatric” hospitals. I am involved with testicular cancer both as a clinician and as a researcher. My particular areas of focus include: Robotic surgery for testicular cancer, testicular cancer in adolescents and the Long-term effects of testicular-cancer treatment. Dr. Cost’s additional clinical interests are in cancers and tumors in children, adolescents, and adults. Specifically kidney tumors (Wilms Tumor, Renal Cell Carcinoma (RCC), Angiomyolipomas(AML)), Testicular and Para-testicular tumors, and Pelvic Tumors (Rhabdomyosarcomas). This additionally includes patients with tumor predisposition syndromes such as von Hippel Lindau, Tuberous Sclerosis, and Birt-Hogg-Dube. His training in both urologic oncology and pediatric urology has prepared me to care for these patients of all ages and can see them either through Children's Hospital Colorado or through the University Hospital. Dr. Cost is also interested in the use of minimally invasive surgery (robotic-assisted laparoscopy, laparoscopy, single-site laparoscopy, and endoscopy) for all variety of urologic conditions. Within other areas of Pediatric Urology, he is interested in Ureteropelvic junction obstruction, Vesicoureteral reflux, and Urolithiasis (kidney stones).
Read MoreWe are excited and honored to welcome back Dr. Clint Cary as a guest speaker at the Testicular Cancer Conference 2018. Dr. Clint Cary is an Assistant Professor of Urology in the Department of Urology at Indiana University School of Medicine. Dr. Cary is originally from Tennessee and received his undergraduate degree and medical degree from the University of Tennessee. He completed his training in urologic surgery at Indiana University and then completed a 2-year urologic oncology fellowship at the University of California, San Francisco. While in his fellowship, he also completed a Master of Public Heath (MPH) degree with a focus on epidemiology at the University of California, Berkeley.
Read MoreWe are honored and excited to welcome Skip Hudson as a guest speaker at the Testicular Cancer Conference 2018. Skip is an entrepreneur with over 33 years of practical experience as a small business owner (6 companies) or department director for large public and private organizations (7). He also served as President of a health-related non-profit company (TCAF). He is a proven project and program manager.
Read Moreast year BJ Lange was an attendee and this year we are honored to welcome him back as a guest speaker at the Testicular Cancer Conference 2018. BJ Lange is a current resident of Los Angeles and a native to St. Louis, Missouri. BJ is an alumnus of iO West (formerly improvOlympic West), Upright Citizens Brigade Los Angeles, and a graduate of The Second City Hollywood Conservatory, long form program, and musical improv programs. He has also studied at The Groundlings Theater.
Read More
